Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Barker

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Clinical Chemistry|March 14, 2009
Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challengeDavid Cartwright, Paula O'Shea, Odelia Rajanayagam, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2014
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumorsEdward Sausville, Patricia Lorusso, Michael Carducci, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 21, 2019
Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthmaArnaud Bourdin, Dominick Shaw, Andrew Menzies-Gow, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 17, 2024
Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomesDanielle L Jones, Laura C Kusinski, Peter Barker, et al.
Diabetes Care|April 20, 2026
Insulin Hypersecretion and Increased Ectopic Fat in South Asian American Adolescents and Young Adults Compared With White and African American Peers: The CHARISMA StudyTalia A Hitt, Andrea Kelly, Darko Stefanovski, et al.
The Journal of Applied Laboratory Medicine|July 7, 2022
The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating LevelsYanislava Karusheva, Matthew Ratcliff, Alexander Mörseburg, et al.
Lancet (London, England)|September 10, 2016
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trialJ Mark FitzGerald, Eugene R Bleecker, Parameswaran Nair, et al.
British Journal of Clinical Pharmacology|September 30, 2025
An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon-like peptide-1 and glucagon receptor in healthy subjectsJames Goodman, Victoria E Parker, Carmel M McEniery, et al.
Translational Psychiatry|June 25, 2025
Elevated plasma GDF15 combined with FGF21 suggests mitochondrial dysfunction in a subgroup of anorexia nervosa patientsJingjing Xu, Ruyue Zhang, Vincent Millischer, et al.
Brain Imaging and Behavior|August 26, 2015
Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV diseaseLindsay J Hines, Eric N Miller, Charles H Hinkin, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Clinical Chemistry|March 14, 2009
Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challengeDavid Cartwright, Paula O'Shea, Odelia Rajanayagam, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2014
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumorsEdward Sausville, Patricia Lorusso, Michael Carducci, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 21, 2019
Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthmaArnaud Bourdin, Dominick Shaw, Andrew Menzies-Gow, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 17, 2024
Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomesDanielle L Jones, Laura C Kusinski, Peter Barker, et al.
Diabetes Care|April 20, 2026
Insulin Hypersecretion and Increased Ectopic Fat in South Asian American Adolescents and Young Adults Compared With White and African American Peers: The CHARISMA StudyTalia A Hitt, Andrea Kelly, Darko Stefanovski, et al.
The Journal of Applied Laboratory Medicine|July 7, 2022
The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating LevelsYanislava Karusheva, Matthew Ratcliff, Alexander Mörseburg, et al.
Lancet (London, England)|September 10, 2016
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trialJ Mark FitzGerald, Eugene R Bleecker, Parameswaran Nair, et al.
British Journal of Clinical Pharmacology|September 30, 2025
An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon-like peptide-1 and glucagon receptor in healthy subjectsJames Goodman, Victoria E Parker, Carmel M McEniery, et al.
Translational Psychiatry|June 25, 2025
Elevated plasma GDF15 combined with FGF21 suggests mitochondrial dysfunction in a subgroup of anorexia nervosa patientsJingjing Xu, Ruyue Zhang, Vincent Millischer, et al.
Brain Imaging and Behavior|August 26, 2015
Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV diseaseLindsay J Hines, Eric N Miller, Charles H Hinkin, et al.
Pageof 9